The International Energy Agency’s comprehensive energy roadmap models for the first-time report how the world can achieve net-zero carbon emissions in 2050 and limit global warming to 1.5°C. However, while welcoming the report, some environmental NGOs have criticised the IEA. Read the C&I Magazine news article.
US scientists have jammed microparticles with enzymes to detox bees that imbibe organophosphate pesticides.
US scientists report converting polyethylene into jet fuel and lubricants under relatively mild conditions using ruthenium on carbon as a catalyst.
Scientists have made a battery comprised of a polypeptide backbone decorated with viologen and nitroxide radicals. The approach avoids the ethical and environmental issues associated with obtaining lithium and cobalt, key constituents of lithium-ion batteries. Read the C&I Magazine article.
Scientists have developed a new material that improves the resolution of an ordinary light microscope so it can be used to examine fine details in living cells. Read more in C&I Magazine.
Children can suffer an aggressive form of tooth decay from poor dental hygiene and eating lots of fermentable carbohydrates.
A natural analgesic with a long history of use in traditional Chinese medicine could pave the way to a new approach in pain management – by interacting with a recently discovered opioid receptor (Sig. Transduct. Target Ther., doi: 10.1038/s41392-021-00548-w). Read the C&I Magazine news story.
Covid-19 may be a blood-borne disease, infecting humans through the mouth – challenging the current view the virus is inhaled into the lungs as in respiratory diseases like the flu, a new paper hypothesises. This new model of SARS-CoV-2 infection could, if proven, affect how Covid-19 is prevented and treated. Read more in C&I Magazine.
The Dutch government will provide subsidies of around €2bn to a consortium including Royal Dutch Shell and ExxonMobil for what is set to become one of the largest carbon capture and storage (CCS) projects in the world at the Port of Rotterdam.
A new kind of vaccine may offer protection against a range of coronaviruses, animal studies show. A Duke University, US, research group developed the approach using a nanoparticle studded with 24 segments of the spike protein from SARS-CoV-2. It generated an outstanding antibody response against the pandemic virus in monkeys (Nature, doi: 10.1038/s41586-021-03594-0).